Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992
- PMID: 1295764
- DOI: 10.1007/BF01967804
Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992
Abstract
Rates of antibiotic resistance within the Bacteroides fragilis group were monitored over a 15-year period in France by examining studies that employed the same methodology to test susceptibility of anaerobic bacteria. Chloramphenicol, metronidazole, beta-lactam/beta-lactamase inhibitor combinations and imipenem remained very active against Bacteroides fragilis. There was little or no change in rates of resistance to these antibiotics. Resistance to clindamycin increased from 1% in 1977 to a peak of 19% in 1987, and since then has remained at 8 to 12%. There was some evidence that resistance to most beta-lactam agents increased during the same period. These results emphasize the need for periodic surveys of resistance patterns of the Bacteroides fragilis group in each country.
Similar articles
-
Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989.Eur J Clin Microbiol Infect Dis. 1992 Apr;11(4):352-6. doi: 10.1007/BF01962077. Eur J Clin Microbiol Infect Dis. 1992. PMID: 1396757
-
Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.Pathology. 1988 Jul;20(3):260-3. doi: 10.3109/00313028809059504. Pathology. 1988. PMID: 3205597
-
The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987.J Antimicrob Chemother. 1990 Jun;25(6):1011-9. doi: 10.1093/jac/25.6.1011. J Antimicrob Chemother. 1990. PMID: 2370237
-
Susceptibility of anaerobic bacteria to beta-lactam antibiotics in the United States.Clin Infect Dis. 1993 Jun;16 Suppl 4:S371-6. doi: 10.1093/clinids/16.supplement_4.s371. Clin Infect Dis. 1993. PMID: 8324150 Review.
-
Newer beta-lactam agents and the Bacteroides fragilis group.Pharmacotherapy. 1991;11(2 ( Pt 2)):51S-55S. Pharmacotherapy. 1991. PMID: 2041832 Review.
Cited by
-
Decreased susceptibility to nitroimidazoles among Bacteroides species in Brazil.Curr Microbiol. 2006 Jan;52(1):27-32. doi: 10.1007/s00284-005-0068-0. Epub 2005 Dec 26. Curr Microbiol. 2006. PMID: 16391998
-
In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms.Antimicrob Agents Chemother. 1996 Oct;40(10):2266-70. doi: 10.1128/AAC.40.10.2266. Antimicrob Agents Chemother. 1996. PMID: 8891127 Free PMC article.
-
In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria.Antimicrob Agents Chemother. 2003 Nov;47(11):3667-71. doi: 10.1128/AAC.47.11.3667-3671.2003. Antimicrob Agents Chemother. 2003. PMID: 14576144 Free PMC article.
-
Susceptibility testing of anaerobic bacteria: evaluation of the redesigned (Version 96) bioMérieux ATB ANA device.J Clin Microbiol. 1999 Jun;37(6):1824-8. doi: 10.1128/JCM.37.6.1824-1828.1999. J Clin Microbiol. 1999. PMID: 10325331 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Medical